Suppr超能文献

RNA聚合酶III转录的核酶在体内活性的调控因素。

Factors governing the activity in vivo of ribozymes transcribed by RNA polymerase III.

作者信息

Koseki S, Tanabe T, Tani K, Asano S, Shioda T, Nagai Y, Shimada T, Ohkawa J, Taira K

机构信息

National Institute for Advanced Interdisciplinary Research, AIST, MITI, Tsukuba Science City 305-8562, Institute of Medical Science, University of Tokyo, Minato-ku, Tokyo 108-8539, Japan.

出版信息

J Virol. 1999 Mar;73(3):1868-77. doi: 10.1128/JVI.73.3.1868-1877.1999.

Abstract

In order to determine the parameters that govern the activity of a ribozyme in vivo, we made a systematic analysis of chimeric tRNAVal ribozymes by measuring their cleavage activities in vitro as well as the steady-state levels of transcripts, the half-lives of transcribed tRNAVal ribozymes, and their activities in both HeLa and H9 cells. These analyses were conducted by the use of transient expression systems in HeLa cells and stable transformants that express ribozymes. Localization of transcripts appeared to be determined by the higher-order structure of each transcribed tRNAVal ribozyme. Since colocalization of the ribozyme with its target RNA is important for strong activity of the ribozyme in vivo, the best system for tRNA-based expression seems to be one in which the structure of the transcript is different from that of the natural tRNA precursor so that processing of the tRNAVal ribozyme can be avoided. At the same time, the structure of the transcript must be similar enough to allow recognition, probably by an export receptor, so that the transcript can be exported to the cytoplasm to ensure colocalization with its target. In the case of several tRNAVal ribozymes that we constructed, inspection of computer-predicted secondary structures enabled us to control the export of transcripts. We found that only a ribozyme that was transcribed at a high level and that had a sufficiently long half-life, within cells, had significant activity when used to withstand a challenge by human immunodeficiency virus type 1.

摘要

为了确定在体内调控核酶活性的参数,我们通过测量嵌合tRNAVal核酶的体外切割活性、转录本的稳态水平、转录的tRNAVal核酶的半衰期及其在HeLa细胞和H9细胞中的活性,对其进行了系统分析。这些分析是通过在HeLa细胞中使用瞬时表达系统以及表达核酶的稳定转化体来进行的。转录本的定位似乎由每个转录的tRNAVal核酶的高级结构决定。由于核酶与其靶RNA的共定位对于核酶在体内的强大活性很重要,基于tRNA的表达的最佳系统似乎是转录本的结构不同于天然tRNA前体的结构的系统,这样可以避免tRNAVal核酶的加工。同时,转录本的结构必须足够相似以允许(可能通过输出受体)识别,以便转录本可以输出到细胞质中以确保与其靶标共定位。对于我们构建的几种tRNAVal核酶,检查计算机预测的二级结构使我们能够控制转录本的输出。我们发现,只有在细胞内高水平转录且半衰期足够长的核酶,在用于抵抗1型人类免疫缺陷病毒的攻击时才有显著活性。

相似文献

4
Ribozyme expression systems.核酶表达系统。
Methods Mol Biol. 2004;252:195-207. doi: 10.1385/1-59259-746-7:195.
5
Transport of intracellularly active ribozymes to the cytoplasm.细胞内活性核酶向细胞质的转运。
Cancer Chemother Pharmacol. 2001 Aug;48 Suppl 1:S96-101. doi: 10.1007/s002800100314.
6
Use of ribozymes in cellular aging research.核酶在细胞衰老研究中的应用。
Methods Mol Biol. 2007;371:209-26. doi: 10.1007/978-1-59745-361-5_16.
10
Novel method for selection of tRNA-driven ribozymes with enhanced stability in mammalian cells.
Antisense Nucleic Acid Drug Dev. 2002 Oct;12(5):341-52. doi: 10.1089/108729002761381311.

引用本文的文献

7
Novel RNA-based strategies for therapeutic gene silencing.新型基于 RNA 的治疗性基因沉默策略。
Mol Ther. 2010 Mar;18(3):466-76. doi: 10.1038/mt.2009.306. Epub 2010 Jan 19.

本文引用的文献

6
Identification of a nuclear export receptor for tRNA.转运RNA核输出受体的鉴定
Curr Biol. 1998 Mar 12;8(6):305-14. doi: 10.1016/s0960-9822(98)70130-7.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验